Pet-yksikkö

Julkaisut 2003
Publications 2003

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Aaltonen J et al. Production of 235Np, 236 Pu and 237Pu via nuclear reactions on 235,236,238U and 237 Np targets.
2 Aho AJ et al. Remodeling of the tibia after grafting of a large cavity with particulate bioactive glass-hydroxylapatite - case report on treatment of fibrous dysplasia with 13 years' follow-up.
3 Anttila M et al. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects.
4 Bergström K, Någren K. Radiolääkkeet.
5 Bettinardi V et al. Implementation and evaluation of an ordered subsets reconstruction algorithm for transmission PET studies using median root prior and inter-update median filtering.
6 Brust P et al. Positron emission tomography imaging of the serotonin transporter in the pig brain using (11C)(+)-McN5652 and S-((18F)fluoromethyl)-(+)-McN5652.
7 Fujimoto T et al. Skeletal muscle glucose uptake response to exercise in trained and untrained men.
8 Haaparanta M et al. Microdialysis and 2-(18F)fluoro-2-deoxy-D-glucose (FDG): a study on insulin action on FDG transport, uptake and metabolism in rat muscle, liver and adipose tissue.
9 Haarala C et al. Effects of a 902 MHz mobile phone on cerebral blood flow in humans: a PET study.
10 Hagelberg N et al. Altered dopamine D2 receptor binding in atypical facial pain.
11 Hagelberg N et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome.
12 Halldin C, Någren K. PET-radiopharmaceuticals - C11 compounds of clinical value.
13 Hallikainen T et al. Ethanol consumption and DRD2 gene TaqI a polymorphism among socially drinking males.
14 Hemling N et al. Herpesviruses in brains in Alzheimer's and Parkinson's diseases.
15 Hietala J et al. Regional brain morphology and duration of illness in never-medicated first-episode patients with schizophrenia.
16 Hirvonen J et al. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
17 Hällsten K et al. Insulin- and exercise-stimulated skeletal muscle blood flow and glucose uptake in obese men.
18 Hällsten U. Studies of physical processes generated by energetic ions in dense target gases.
19 Härkönen K et al. The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men.
20 Iozzo P et al. Insulin stimulates liver glucose uptake in humans: an 18F-FDG PET study.
21 Iozzo P et al. Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes.
22 Iozzo P et al. Insulin-mediated hepatic glucose uptake is impaired in type 2 diabetes: Evidence for a relationship with glycemic control.
23 Iozzo P et al. Liver uptake of free fatty acids in vivo in humans as determined with 14(R,S)-(18F)fluoro-6-thia-heptadecanoic acid and PET.
24 Janatuinen T. Coronary artery disease risk factors and myocardial blood flow in young adults. With special reference to statin treatment.
25 Janatuinen T et al. Plasma asymmetric demethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults.
26 Jartti L et al. Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis.
27 Joensuu H et al. Boron neutron capture therapy of brain tumors: clinical trials at the Finnish facility using boronphenylalanine.
28 Joyal CC et al. The amygdala and schizophrenia: a volumetric magnetic resonance imaging study in first-episode, neuroleptic-naive patients.
29 Jyrkkiö S et al. PET-tutkimus syövän hoidon suunnittelussa ja hoitovasteen seurannassa.
30 Järvenpää T. Monozygotic twins and cognitive decline with emphasis on Alzheimer's disease. A study of brain imaging changes and alcohol consumption among a population-based twin cohort.
31 Järvenpää T et al. A 90-year-old monozygotic female twin pair discordant for Alzheimer's disease.
32 Järvenpää T et al. Regional cerebral glucose metabolism in monozygotic twins discordant for Alzheimer's disease.
33 Järvisalo M. Arterial changes related to early atherosclerosis in children and adolescents. A high-resolution ultrasound study.
34 Järvisalo M, Raitakari O. Ateroskleroosin varhaismuutokset lapsilla ja nuorilla.
35 Järvisalo MJ et al. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
36 Jääskeläinen SK et al. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia.
37 Kaasinen V et al. Extrastriatal dopamine D2 receptors in Parkinson's disease: a longitudinal study.
38 Kaisti KK et al. Effects of sevoflurane, propofol, and adjunct nitrous oxide on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
39 Kaitosaari T et al. Effect of 7-year infancy-onset dietary intervention on serum lipoproteins and lipoprotein subclasses in healthy children in the prospective, randomized special Turku coronary risk factor intervention project for children (STRIP) study.
40 Kalliokoski K et al. Muscle fractal vascular branching pattern and microvascular perfusion heterogeneity in endurance-trained and untrained men.
41 Kalliokoski K et al. Muscle oxygen extraction and perfusion heterogeneity during continuous and intermittent static exercise.
42 Kalliokoski KK et al. Perfusion distribution between and within muscles during intermittent isometric exercise in endurance-trained and untrained men.
43 Kemppainen J. Skeletal muscle metabolism and perfusion in healthy men and patients with dilated cardomyopathy. With special reference to the effects of training.
44 Kemppainen J et al. Exercise training improves insulin stimulated skeletal muscle glucose uptake independent of changes in perfusion in patients with dilated cardiomyopathy.
45 Kemppainen J et al. Insulin signalling and resistance in patients with chronic heart failure.
46 Kemppainen N et al. Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease.
47 Knuuti J. Sydämen toiminnan tutkimukset positroniemissiotomografialla (PET).
48 Koskenvuo JW et al. Correlation of transthoracic Doppler echocardiography and magnetic resonance imaging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase.
49 Laakso A et al. Personality traits and striatal dopamine synthesis capacity in healthy subjects.
50 Laaksonen MS et al. Skeletal muscle blood flow and flow heterogeneity during dynamic and isometric exercise in humans.
51 Laatu S et al. Visual object recognition in early Alzheimer´s disease; deficits in semantic processing.
52 Langenfeld M et al. Nitric oxide does not mediate the vasodilation of early human pregnancy.
53 Langer O et al. Preparation of 4-(11C)methylmetaraminol, a potential PET tracer for assessment of myocardial sympathetic innervation.
54 Lehtimäki T et al. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men.
55 Lehtiö K. Imaging Perfusion and Hypoxia in Head and Neck Cancer Using Positron Emission Tomography (PET).
56 Lehtiö K et al. Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ((18F)FETNIM) and PET using the tumour to plasma ratio.
57 Långsjö J et al. Effects of subanesthetic doses of ketamine on regional cerebral blood flow, oxygen consumption, and blood volume in humans.
58 Mac Manus MP et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer.
59 Marjamäki P et al. S-(18F)fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
60 Mattila KM et al. Absence of association between an intercellular adhesion molecule 1 gene E469 polymorphism and Alzheimer's disease in Finnish patients.
61 Minn H. Kasvainten PET-kuvaukset.
62 Minn H, Knuuti J. PET-tutkimus kliinisessä käytössä.
63 Minn H et al. Lyhytikäiset isotoopit syöpätautien diagnostiikassa.
64 Mäkelä T et al. A 3-D model-based registration approach for the PET, MR and MCG cardiac data fusion.
65 Nurmi E et al. Progression of dopaminergic hypofunction in striatal subregions in Parkinson´s disease using 18F-CFT PET.
66 Någren K. PET and knockout mice in drug discovery.
67 Penttilä J et al. Effect of cardiac vagal outflow on complexity and fractal correlation properties of heart rate dynamics.
68 Raitakari OT et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood. The cardiovascular risk in young Finns study.
69 Renvall K et al. Naming of multiple objects: neural correlates as measured by positron emission tomography.
70 Rinne J. Uutta Alzheimerin taudista.
71 Rinne J. Endogenous dopamine release in Parkinson's disease.
72 Rinne J et al. Aivojen PET-tutkimukset - kliinisiä sovelluksia.
73 Rinne JO et al. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
74 Rinne JO et al. Semantic decision making in early probable AD: a PET activation study.
75 Rinne JO et al. Catechol-0-methyl transferase (COMT) inhibitors in patients with Parkinson's disease.
76 Roivainen A et al. Use of positron emission tomography with methyl-11C-choline and 2-18F-fluoro-2-deoxy-D-glucose in comparison with magnetic resonance imaging for the assessment of inflammatory proliferation of synovium.
77 Räsänen JV et al. Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction.
78 Stolen K et al. Exercise training improves insulin-stimulated myocardial glucose uptake in patients with dilated cardiomyopathy.
79 Stolen KQ et al. Exercise training improves biventricular oxidative metabolism and left ventricular efficiency in patients with dilated cardiomyopathy.
80 Stolen KQ. The effects of exercise training on myocardial function and metabolism in patients with idiopathic cardiomyopathy. Studies using Positron Emission Tomography.
81 Sundell J et al. High serum leptin is associated with attenuated coronary vasoreactivity.
82 Sundell J, Knuuti J. Insulin and myocardial blood flow.
83 Sundell J et al. Blunted coronary vasoreactivity to insulin is an early alternation in hypertension.
84 Sutinen E et al. Uptake of (N-methyl-11C)alfa-methylaminoisobutyric acid in untreated head and neck cancer studied by PET.
85 Utriainen M et al. Evaluation of brain tumor metabolism with [11C] choline PET and 1H-MRS.
86 Virtanen K. Insulin-stimulated glucose uptake in adipose tissue. Positron emission tomography studies in obesity and type 2 diabetes.
87 Virtanen KA et al. Differential effects of rosiglitazone and Metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects.
88 Yu M et al. Radiolabeling and biodistribution of methyl 2-(methoxycarbonyl)-2-(methylamino) bicyclo (2.1.1) - hexane -5-carboxylate, a potential neuroprotective drug.
Julkaisutietokanta 29.9.2004 Publications Data Base 29.9.2004